PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Details
- Status
- Prescription
- First Approved
- 2025-05-30
- Routes
- INTRAVENOUS
- Dosage Forms
- SOLUTION
PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE Approval History
What PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE Treats
8 indicationsPHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE is approved for 8 conditions since its original approval in 2025. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Cough
- Nasal Congestion
- Pain
- Sore Throat
- Headache
- Runny Nose
- Sneezing
- Fever
Drugs Similar to PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE FDA Label Details
ProIndications & Usage
FDA Label (PDF)Uses temporarily relieves these common cold and flu symptoms: cough nasal congestion minor aches and pains sore throat headache runny nose sneezing temporarily reduces fever controls cough to help your child get to sleep
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.